规模突破万亿元 跨境ETF成“一键配置全球”核心工具

Core Insights - The total scale of cross-border ETFs in China's public fund industry has historically surpassed 1 trillion yuan, reaching 10,164.21 billion yuan as of January 14, 2026, marking a significant milestone in the industry [1] - Cross-border ETFs have transitioned from a marginal investment option to a crucial channel for global asset allocation for residents, reflecting a surge in demand for global investment opportunities [1] Growth Drivers - Since the beginning of 2026, cross-border ETFs have experienced an average growth rate of 5.9%, with a remarkable annual increase of 37%, particularly driven by strong performance in Hong Kong stock products [2] - Notable net inflows have been recorded, with over 10 billion yuan in net inflows for just two products, indicating robust investor interest [2] - The number of cross-border ETFs exceeding 10 billion yuan in scale has reached 26, with four leading products surpassing 40 billion yuan [2] Advantages for Investors - Cross-border ETFs offer advantages such as a minimum investment of 100 yuan and T+0 trading, enabling ordinary investors to access global markets at a low cost [3] - These funds serve as a compliant and efficient bridge for residents to invest overseas, allowing them to share in global industry dividends, particularly in sectors like AI and innovative pharmaceuticals [3] Market Dynamics and Risks - The average premium of cross-border ETFs is 0.42%, with some products showing premiums exceeding 20%, indicating potential overvaluation and associated risks [4] - The presence of high premiums suggests that asset prices may already reflect optimistic expectations, which could lead to price volatility due to future corrections or liquidity changes [4] Future Outlook - The globalization of the public fund industry is expected to enhance the cross-border capabilities and product innovation of fund companies [5] - There is a need for public institutions to strengthen research on overseas markets and multi-currency operations, while expanding coverage of emerging markets and global sectors like AI and innovative pharmaceuticals [5] - The industry is anticipated to evolve from broad-based ETFs to more specialized themes, creating a comprehensive product ecosystem that spans both mature and emerging markets [5]